{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T15:16:35Z","timestamp":1789917395699,"version":"4.0.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,14]],"date-time":"2016-09-14T00:00:00Z","timestamp":1473811200000},"content-version":"vor","delay-in-days":349,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.ejphar.2015.09.002","type":"journal-article","created":{"date-parts":[[2015,9,8]],"date-time":"2015-09-08T20:02:00Z","timestamp":1441742520000},"page":"375-383","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Chronic fluoxetine treatment increases NO bioavailability and calcium-sensitive potassium channels activation in rat mesenteric resistance arteries"],"prefix":"10.1016","volume":"765","author":[{"given":"Camila A.","family":"Pereira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathanne S.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiola L.","family":"Mestriner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Antunes-Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo R.B.","family":"Evora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo B.M.","family":"Resstel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando S.","family":"Carneiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita C.","family":"Tostes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2015.09.002_bib1","doi-asserted-by":"crossref","first-page":"B130","DOI":"10.1093\/geronj\/47.4.B130","article-title":"Effects of the selective serotonin reuptake inhibitor fluoxetine on baroreceptor reflex sensitivity and body weight in young and old rats","volume":"47","author":"Alper","year":"1992","journal-title":"J. Gerontol."},{"key":"10.1016\/j.ejphar.2015.09.002_bib2","unstructured":"ANVISA, 2006. Bul\u00e1rio Eletr\u00f4nico da ANVISA \u2013 Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria."},{"key":"10.1016\/j.ejphar.2015.09.002_bib3","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/368850a0","article-title":"Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle","volume":"368","author":"Bolotina","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2015.09.002_bib4","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejphar.2015.09.002_bib5","doi-asserted-by":"crossref","first-page":"9030","DOI":"10.1073\/pnas.86.22.9030","article-title":"Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum","volume":"86","author":"Bredt","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2015.09.002_bib6","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/sj.npp.1300961","article-title":"Alteration of decreased plasma NO metabolites and platelet NO synthase activity by paroxetine in depressed patients","volume":"31","author":"Chrapko","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2015.09.002_bib7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.brainres.2010.09.049","article-title":"Fluoxetine prevents LPS-induced degeneration of nigral dopaminergic neurons by inhibiting microglia-mediated oxidative stress","volume":"1363","author":"Chung","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2015.09.002_bib8","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ejphar.2011.09.030","article-title":"Chronic fluoxetine treatment alters cardiovascular functions in unanesthetized rats","volume":"670","author":"Crestani","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.09.002_bib9","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/0304-3940(94)90185-6","article-title":"Inhibition of a 5-HT3 receptor-mediated current by the selective serotonin uptake inhibitor\u00a0fluoxetine","volume":"173","author":"Fan","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2015.09.002_bib10","unstructured":"FDA, 2014. Electronic Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations, Food and Drug Administration Website, 34 ed."},{"key":"10.1016\/j.ejphar.2015.09.002_bib11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/hup.1014","article-title":"Oxidative stress parameters after combined fluoxetine and acetylsalicylic acid therapy in depressive patients","volume":"24","author":"Galecki","year":"2009","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2015.09.002_bib12","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/33934","article-title":"Dynamic activation of endothelial nitric oxide synthase by Hsp90","volume":"392","author":"Garcia-Cardena","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2015.09.002_bib13","doi-asserted-by":"crossref","first-page":"C1119","DOI":"10.1152\/ajpcell.1993.264.5.C1119","article-title":"Modulation of rabbit aortic Ca(2+)-activated K+ channels by pinacidil, cromakalim, and glibenclamide","volume":"264","author":"Gelband","year":"1993","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2015.09.002_bib14","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1161\/01.HYP.31.1.266","article-title":"Nitric oxide synthase activity and renal injury in genetic hypertension","volume":"31","author":"Hayakawa","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2015.09.002_bib15","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jagp.2013.01.018","article-title":"The association of selective serotonin reuptake inhibitors use and stroke in geriatric population","volume":"21","author":"Hung","year":"2013","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.ejphar.2015.09.002_bib16","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.pnpbp.2009.07.028","article-title":"Effects of antidepressants on plasma metabolites of nitric oxide in major depressive disorder: comparison between milnacipran and paroxetine","volume":"33","author":"Ikenouchi-Sugita","year":"2009","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2015.09.002_bib17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/10739680590896072","article-title":"Potassium channels in the peripheral microcirculation","volume":"12","author":"Jackson","year":"2005","journal-title":"Microcirculation"},{"key":"10.1016\/j.ejphar.2015.09.002_bib18","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0006-3223(03)00568-7","article-title":"Depression and cardiovascular disease: mechanisms of interaction","volume":"54","author":"Joynt","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2015.09.002_bib19","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1744-8069-5-12","article-title":"Nitric oxide activates ATP-sensitive potassium channels in mammalian sensory neurons: action by direct S-nitrosylation","volume":"5","author":"Kawano","year":"2009","journal-title":"Mol. Pain"},{"key":"10.1016\/j.ejphar.2015.09.002_bib20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bbr.2010.11.027","article-title":"The antidepressant action of imipramine and venlafaxine involves suppression of nitric oxide synthesis","volume":"218","author":"Krass","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2015.09.002_bib21","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/01.jcp.0000085416.08426.1d","article-title":"Paroxetine-induced increase in metabolic end products of nitric oxide","volume":"23","author":"Lara","year":"2003","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2015.09.002_bib22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4306\/pi.2010.7.1.55","article-title":"Antidepressant-induced sexual dysfunction among newer antidepressants in a naturalistic setting","volume":"7","author":"Lee","year":"2010","journal-title":"Psychiatry Investig."},{"key":"10.1016\/j.ejphar.2015.09.002_bib23","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0361-9230(01)00566-4","article-title":"Effects of acute and chronic fluoxetine treatments on restraint stress-induced Fos expression","volume":"55","author":"Lino-de-Oliveira","year":"2001","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2015.09.002_bib24","first-page":"519","article-title":"Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone associated with the use of selective serotonin reuptake inhibitors: a review of spontaneous reports","volume":"155","author":"Liu","year":"1996","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.ejphar.2015.09.002_bib25","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1161\/01.HYP.9.2.157","article-title":"Endothelium-dependent vascular responses in normotensive and hypertensive Dahl rats","volume":"9","author":"Luscher","year":"1987","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2015.09.002_bib26","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/sj.bjp.0702314","article-title":"Block by fluoxetine of volume-regulated anion channels","volume":"126","author":"Maertens","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.09.002_bib27","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/sj.mp.4000392","article-title":"Effects of fluoxetine on wild and mutant neuronal alpha 7 nicotinic receptors","volume":"3","author":"Maggi","year":"1998","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ejphar.2015.09.002_bib28","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/00019442-200401000-00011","article-title":"Post-stroke and clinically-defined vascular depression in geriatric rehabilitation patients","volume":"12","author":"Mast","year":"2004","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.ejphar.2015.09.002_bib29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1161\/CIRCRESAHA.109.198234","article-title":"Nitric oxide-independent vasodilator rescues heme-oxidized soluble guanylate cyclase from proteasomal degradation","volume":"105","author":"Meurer","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2015.09.002_bib31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1161\/01.RES.41.1.19","article-title":"Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats","volume":"41","author":"Mulvany","year":"1977","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2015.09.002_bib32","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1073\/pnas.94.5.2036","article-title":"Blockage of 5HT2C serotonin receptors by fluoxetine (Prozac)","volume":"94","author":"Ni","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2015.09.002_bib33","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1111\/j.1582-4934.2012.01596.x","article-title":"Fluoxetine induces vasorelaxation of cerebral arterioles by co-modulating NO\/muscarinic signaling","volume":"16","author":"Ofek","year":"2012","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejphar.2015.09.002_bib34","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1139\/y01-030","article-title":"Serotonin reuptake inhibitors fluoxetine and citalopram relax intestinal smooth muscle","volume":"79","author":"Pacher","year":"2001","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.09.002_bib35","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/sj.bjp.0702571","article-title":"Serotonin reuptake inhibitor, fluoxetine, dilates isolated skeletal muscle arterioles. Possible role of altered Ca2+ sensitivity","volume":"127","author":"Pacher","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.09.002_bib36","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2174\/0929867306666220330184544","article-title":"Speculations on difference between tricyclic and selective serotonin reuptake inhibitor antidepressants on their cardiac effects\u00a0Is there any?","volume":"6","author":"Pacher","year":"1999","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejphar.2015.09.002_bib37","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0022-3565(24)37206-4","article-title":"Inhibition of neuronal Na+ channels by antidepressant drugs","volume":"284","author":"Pancrazio","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2015.09.002_bib38","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3349\/ymj.1999.40.2.144","article-title":"Fluoxetine inhibits L-type Ca2+ and transient outward K+ currents in rat ventricular myocytes","volume":"40","author":"Park","year":"1999","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.ejphar.2015.09.002_bib39","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S0022-3565(24)29480-5","article-title":"Effects of anorexinogen agents on cloned voltage-gated K(+) channel hKv1.5","volume":"298","author":"Perchenet","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2015.09.002_bib40","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1176\/ajp.140.8.1072","article-title":"Hypertension and DSM-III depression in psychiatric outpatients","volume":"140","author":"Rabkin","year":"1983","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2015.09.002_bib41","first-page":"119","article-title":"Effects of amitriptyline, fluoxetine, tranylcypromine and venlafaxine on rat vascular smooth muscle in vitro \u2013 the role of the endothelium","volume":"63","author":"Ribback","year":"2012","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.09.002_bib42","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1124\/jpet.300.2.543","article-title":"The antidepressant drug fluoxetine is an inhibitor of human ether-a-go-go-related gene (HERG) potassium channels","volume":"300","author":"Thomas","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2015.09.002_bib43","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1176\/appi.ajp.2008.08060817","article-title":"Selective serotonin reuptake inhibitor use and risk of gestational hypertension","volume":"166","author":"Toh","year":"2009","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2015.09.002_bib45","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1161\/01.HYP.13.6.658","article-title":"Endothelium and control of vascular function. State of the art lecture","volume":"13","author":"Vanhoutte","year":"1989","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2015.09.002_bib46","unstructured":"Verispan, V., 2012. Top 200 Drugs for 2005 by Sales, p. \u3008www.drugs.com\u3009."},{"key":"10.1016\/j.ejphar.2015.09.002_bib48","doi-asserted-by":"crossref","first-page":"181S","DOI":"10.1093\/ajcn\/55.1.181s","article-title":"Clinical studies with fluoxetine in obesity","volume":"55","author":"Wise","year":"1992","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ejphar.2015.09.002_bib49","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.neulet.2015.05.043","article-title":"Antidepressant action via the nitric oxide system: a pilot study in an acute depressive model induced by arginin","volume":"599","author":"Yoshino","year":"2015","journal-title":"Neurosci. Lett."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991530234X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991530234X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T14:10:49Z","timestamp":1748614249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429991530234X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":46,"alternative-id":["S001429991530234X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2015.09.002","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic fluoxetine treatment increases NO bioavailability and calcium-sensitive potassium channels activation in rat mesenteric resistance arteries","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2015.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}